NFATc4 Constitutive Nuclear Retention as a Driver of Sarcopenic Fast-Fiber Atrophy: The 'Transcriptional Limbo' Hypothesis

Hypothesis: In aging skeletal muscle, age-related Ca2+ dysregulation triggers calcineurin hyperactivation, leading to sustained NFATc4 nuclear retention that paradoxically induces a "transcriptional limbo"—simultaneously suppressing the slow-fiber oxidative program while failing to properly maintain the fast-fiber transcriptional program, thereby accelerating atrophy through loss of both fiber type identities.

Mechanistic Reasoning:

Previous work established that NFATc4 shows constitutive nuclear accumulation in both slow and fast fibers under basal conditions, potentially supporting a default fast-fiber transcriptional program independent of nerve activity [1]. However, NFATc4 dynamics in sarcopenic muscle remain unexplored. Building on evidence that age-related Ca2+ dysregulation leads to calcineurin/NFAT pathway hyperactivation in non-muscle tissues [2], we propose this same mechanism operates in aging muscle.

We suggest that chronic calcineurin hyperactivation creates an NFATc4 "overload" state—where NFATc4 remains nuclear but becomes functionally dysregulated. Unlike NFATc1, which exhibits activity-dependent shuttling and declines during neuromuscular blockade [3], NFATc4's constitutive nuclear presence may render it resistant to normal export signals. With age, chronic Ca2+ leak from damaged sarcoplasmic reticulum and mitochondrial dysfunction could maintain elevated calcineurin activity, locking NFATc4 in the nucleus.

Testable Predictions:

1. NFATc4 nuclear/cytoplasmic ratio will be significantly elevated in aged skeletal muscle compared to young controls
2. RNA-seq of aged fast fibers will reveal downregulation of both fast-type genes (MyHC-2B, 2X) AND slow-type genes (MyHC-slow, oxidative phosphorylation genes), consistent with transcriptional limbo
3. Chromatin immunoprecipitation will demonstrate NFATc4 binding to promoters of both fiber-type genes and atrogenes (MuRF1, MAFbx), with increased binding in aged muscle
4. Cyclosporin A treatment in aged mice will partially restore NFATc4 shuttling and reduce atrophy markers
5. Calcineurin overexpression in young muscle will phenocopy aged NFATc4 nuclear retention and fast-fiber atrophy

Falsifiability: This hypothesis would be falsified if NFATc4 nuclear levels decrease or remain unchanged in aged muscle, or if atrogenes show no correlation with NFATc4 activity. If calcineurin inhibition fails to improve aged muscle function despite NFATc4 redistribution, the causal mechanism would be rejected.

References: [1] https://pmc.ncbi.nlm.nih.gov/articles/PMC2726382/ [2] https://www.frontiersin.org/journals/aging-neuroscience/articles/10.3389/fnagi.2018.00199/full [3] https://pmc.ncbi.nlm.nih.gov/articles/PMC2014727/